Eli Lilly and Company (LLY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 724.87 |
| Open | 723.48 |
| Bid | 733.01 x 1000 |
| Ask | 733.20 x 1100 |
| Day's range | 721.00 - 737.45 |
| 52-week range | 392.26 - 800.78 |
| Volume | |
| Avg. volume | 3,066,637 |
| Market cap | 697.396B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 126.47 |
| EPS (TTM) | 5.80 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | 5.20 (0.72%) |
| Ex-dividend date | 14 Feb 2024 |
| 1y target est | 826.94 |
Investor's Business DailyDow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
Investor's Business DailyHow 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Investor's Business DailyIs Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
© 2024 Yahoo. All rights reserved.